[Pyrrolo-rifamycin: synthesis and antibacterial properties].
D000818:Animals; D002855:Chromatography, Thin Layer; D013293:Enterococcus faecalis / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D007271:Injections, Intradermal; D007408:Intestinal Absorption; D051379:Mice; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D011758:Pyrroles / Q000008:administration & dosage / Q000138:chemical synthesis* / Q000494:pharmacology*; D012293:Rifampin / Q000008:administration & dosage / Q000138:chemical synthesis* / Q000494:pharmacology*; D013210:Staphylococcus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects
D011758:Pyrroles; D012293:Rifampin
Pirrolo-rifamicine: sintesi e proprietà antibatteriche.